Siang Hui Lai

Siang Hui Lai

Auto-generated profile, based on publicly available information

Siang Hui Lai

Department of Pathology, Singapore General Hospital, Singapore

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2015 in Brain Pathology
Verified
Journal Article
Closed access
PDF file
SASanda Alexandrescu
Sanda Alexandrescu
Andrey KorshunovAndrey Korshunov
Andrey Korshunov
SLSiang Hui Lai
Siang Hui Lai
SDSalma Dabiri
Salma Dabiri
SPSushama Patil
Sushama Patil
APArie Perry
Arie Perry

12 August 2020 in BMC Medical Education
Verified
Journal Article
Open access
PDF file
RJRaihan Jumat
Raihan Jumat
PCPierce Kah-Hoe Chow
Pierce Kah-Hoe Chow
JAJohn Carson Allen
John Carson Allen
SLSiang Hui Lai
Siang Hui Lai
NHNian-Chih Hwang
Nian-Chih Hwang
SCScott Compton
Scott Compton
Background: Burnout is a serious issue plaguing the medical profession with potential negative consequences on patient care. Burnout symptoms are observed as early as medical school. Based on a Job Demands-Resources model, this study aims to assess associations between specific job resources measured at the beginning of the first year of medical school with burnout symptoms occurring later in the first year.Methods: The specific job resources of grit, tolerance for ambiguity, social support and gender were measured in Duke-NUS Medical School students at the start of Year 1. Students were then surveyed for burnout symptoms at approximately quarterly intervals throughout the year. Using high ratings of cynicism and exhaustion as the definition of burnout, we investigated the associations of the occurrence of burnout with student job resources using multivariable logistic regression analysis.Results: Out of 59 students, 19 (32.2%) indicated evidence of burnout at some point across the first year of medical school. Stepwise multivariable logistic regression analysis identified grit as having a significant protective effect against experiencing burnout (Odds Ratio, 0.84; 95%CI 0.74 to 0.96). Using grit as a single predictor of burnout, area under the ROC curve was 0.76 (95%CI: 0.62 to 0.89).Conclusions: Grit was identified as a protective factor against later burnout, suggesting that less gritty students are more susceptible to burnout. The results indicate that grit is a robust character trait which can prognosticate burnout in medical students. These students would potentially benefit from enhanced efforts to develop grit as a personal job resource.

1 October 2006 in Forensic Science International
Verified
Journal Article
Closed access
SLSiang Hui Lai
Siang Hui Lai
YYYi Ju Yao
Yi Ju Yao
DLDanny Siaw Teck Lo
Danny Siaw Teck Lo

1 February 2001 in Forensic Science International
Verified
Journal Article
Closed access
GLGilbert Lau
Gilbert Lau
SLSiang Hui Lai
Siang Hui Lai

11 April 2015 in BMC Cancer
Verified
Journal Article
Open access
PDF file
DCDawn Q Chong
Dawn Q Chong
XTXin Y Toh
Xin Y Toh
IHIvy A. W. Ho
Ivy A. W. Ho
KSKian Chuan Sia
Kian Chuan Sia
JNJennifer P Newman
Jennifer P Newman
PLPaula Yp Lam
Paula Yp Lam
The treatment of glioblastoma multiforme (GBM) is an unmet clinical need. The 5-year survival rate of patients with GBM is less than 3%. Temozolomide (TMZ) remains the standard first-line treatment regimen for gliomas despite the fact that more than 90% of recurrent gliomas do not respond to TMZ after repeated exposure. We have also independently shown that many of the Asian-derived glioma cell lines and primary cells derived from Singaporean high-grade glioma patients are indeed resistant to TMZ. This issue highlights the need to develop new effective anti-cancer treatment strategies. In a recent study, wild-type epidermal growth factor receptor (wtEGFR) has been shown to phosphorylate a truncated EGFR (known as EGFRvIII), leading to the phosphorylation of STAT proteins and progression in gliomagenesis. Despite the fact that combination of EGFR targeting drugs and rapamycin has been used before, the effect of mono-treatment of Nimotuzumab, rapamycin and combination therapy in human glioma expressing different types of EGFR is not well-studied. Herein, we evaluated the efficacy of dual blockage using monoclonal antibody against EGFR (Nimotuzumab) and an mTOR inhibitor (rapamycin) in Caucasian patient-derived human glioma cell lines, Asian patient-derived human glioma cell lines, primary glioma cells derived from the Mayo GBM xenografts, and primary short-term glioma culture derived from high-grade glioma patients. The combination effect of Nimotuzumab and rapamycin was examined in a series of primary human glioma cell lines and glioma cell lines. The cell viability was compared to TMZ treatment alone. Endogenous expressions of EGFR in various GBM cells were determined by western blotting. The results showed that combination of Nimotuzumab with rapamycin significantly enhanced the therapeutic efficacy of human glioma cells compared to single treatment. More importantly, many of the Asian patient-derived glioma cell lines and primary cells derived from Singaporean high-grade gliomas, which showed resistance to TMZ, were susceptible to the combined treatments. In conclusion, our results strongly suggest that combination usage of Nimotuzumab and rapamycin exert higher cytotoxic activities than TMZ. Our data suggest that this combination may provide an alternative treatment for TMZ-resistant gliomas regardless of the EGFR status.

12 June 2020 in Medical Education
Verified
Journal Article
Closed access
PDF file
ILIrene Cheng Jie Lee
Irene Cheng Jie Lee
HKHuishan Koh
Huishan Koh
SLSiang Hui Lai
Siang Hui Lai
NHNian Chih Hwang
Nian Chih Hwang